xmlui.ArtifactBrowser.ConfigurableBrowse.title.metadata.subject_decs
Ara mostrant els elements 1-20 d 81
-
A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis
(MDPI, 2019-11-20) -
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer
(Oxford University Press, 2023-03) -
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer
(American Association for Cancer Research, 2023-06-15) -
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer
(MDPI, 2021-04-17) -
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
(SAGE Publications, 2021-01) -
Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy
(American Medical Association, 2022-11) -
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
(Nature Research, 2019-02-22)